Bio-Techne TECH Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's total current liabilities?
- Bio-Techne (TECH) reported total current liabilities of $153.28M in Q1 2026.
- How has Bio-Techne's total current liabilities changed year-over-year?
- Bio-Techne's total current liabilities decreased by 9.4% year-over-year, from $169.2M to $153.28M.
- What is the long-term trend for Bio-Techne's total current liabilities?
- Over 4 years (2021 to 2025), Bio-Techne's total current liabilities has grown at a 3.7% compound annual growth rate (CAGR), from $152.28M to $175.85M.
- What does total current liabilities mean?
- The total amount of debt and other obligations the company must pay within the next year.
- How do you interpret total current liabilities?
- A high ratio relative to current assets may signal liquidity risk, while a manageable level indicates healthy working capital.
- How does total current liabilities compare across companies?
- Should be compared against current assets to determine the current ratio, a standard liquidity benchmark.